REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study

We aimed to evaluate the real-world effectiveness and safety of tofacitinib for the treatment of ulcerative colitis (UC). METHODS: REMIT-UC is a Canadian multicenter cohort study. Standardized data collection was performed on 334 consecutive adult outpatients with UC treated with tofacitinib. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Christopher, Panaccione, Remo, Xiao, Yasi, Khandelwal, Yuvan, Murthy, Sanjay K., Wong, Emily C.L., Narula, Neeraj, Tsai, Catherine, Peerani, Farhad, Reise-Filteau, Marica, Bressler, Brian, Starkey, Samantha Y., Loomes, Dustin, Sedano, Rocio, Jairath, Vipul, Bessissow, Talat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144270/
https://www.ncbi.nlm.nih.gov/pubmed/36580497
http://dx.doi.org/10.14309/ajg.0000000000002129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144270/
https://www.ncbi.nlm.nih.gov/pubmed/36580497
http://dx.doi.org/10.14309/ajg.0000000000002129

Ejemplares similares